Modeling sequential systemic therapy for unresectable hepatocellular carcinoma in the era of immunotherapy: What comes next?

被引：0
|
作者：
Celsa, Ciro [1 ]
Cabibbo, Giuseppe [1 ]
Enea, Marco [1 ]
Battaglia, Salvatore [1 ]
Rizzo, Giacomo Emanuele Maria [1 ]
Camma, Calogero [2 ]
机构：
[1] Univ Palermo, Palermo, Italy
[2] Univ Palermo, Sect Gastroenterol & Hepatol, PROMISE, Palermo, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 03期
关键词：
D O I：
10.1200/JCO.2021.39.3_suppl.324
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
324
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy
    Farasati Far, Bahareh
    Rabie, Dorsa
    Hemati, Parisa
    Fooladpanjeh, Parastoo
    Faal Hamedanchi, Neda
    Broomand Lomer, Nima
    Karimi Rouzbahani, Arian
    Naimi-Jamal, Mohammad Reza
    LIVERS, 2023, 3 (01): : 121 - 160
  • [22] Letter: sequential or combined systemic treatment for unresectable hepatocellular carcinoma-authors' reply
    Kirstein, Martha M.
    Scheiner, Bernhard
    Pinter, Matthias
    Vogel, Arndt
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (05) : 917 - 918
  • [23] A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
    Kudo, M.
    LIVER CANCER, 2017, 6 (03) : 177 - 184
  • [24] Efficacy of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma in immunotherapy era clinical practice
    Hiraoka, Atsushi
    Tada, Toshifumi
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    Ohama, Hideko
    Toyoda, Hidenori
    Ogawa, Chikara
    Nishimura, Takashi
    Hatanaka, Takeshi
    Kakizaki, Satoru
    Kawata, Kazuhito
    Naganuma, Atsushi
    Kosaka, Hisashi
    Matono, Tomomitsu
    Kuroda, Hidekatsu
    Yata, Yutaka
    Nishikawa, Hiroki
    Imai, Michitaka
    Aoki, Tomoko
    Ochi, Hironori
    Tada, Fujimasa
    Nakamura, Shinichiro
    Nakamura, Yoshiko
    Nouso, Kazuhiro
    Morishita, Asahiro
    Itokawa, Norio
    Okubo, Tomomi
    Arai, Taeang
    Tsutsui, Akemi
    Nagano, Takuya
    Tanaka, Kazunari
    Tanaka, Hironori
    Koshiyama, Yuichi
    Kanayama, Yuki
    Noritake, Hidenao
    Enomoto, Hirayuki
    Kaibori, Masaki
    Hiasa, Yoichi
    Kudo, Masatoshi
    Kumada, Takashi
    HEPATOLOGY RESEARCH, 2025, 55 (03) : 444 - 453
  • [25] Hepatocellular carcinoma downstaging for liver transplantation in the era of systemic combined therapy with anti-VEGF/TKI and immunotherapy
    Tran, Nguyen H.
    Munoz, Sergio
    Thompson, Scott
    Hallemeier, Christopher L.
    Bruix, Jordi
    HEPATOLOGY, 2022, 76 (04) : 1203 - 1218
  • [26] Lenvatinib as a therapy for unresectable hepatocellular carcinoma
    Spallanzani, Andrea
    Orsi, Giulia
    Andrikou, Kalliopi
    Gelsomino, Fabio
    Rimini, Margherita
    Riggi, Laura
    Cascinu, Stefano
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (11) : 1069 - 1076
  • [27] THERAPY OF UNRESECTABLE HEPATOCELLULAR-CARCINOMA
    LEVIN, B
    AMOS, C
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (19): : 1294 - 1296
  • [28] The Impact of Sequential Therapies after First-Line Systemic Therapies in Unresectable Hepatocellular Carcinoma
    Lee, Shou-Wu
    Lee, Teng-Yu
    Yang, Sheng-Shun
    Huang, Yi-Jie
    Peng, Yen-Chun
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
  • [29] Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma
    Jaeger, HJ
    Mehring, UM
    Castaneda, F
    Hasse, F
    Blumhardt, G
    Loehlein, D
    Mathias, KD
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 1996, 19 (06) : 388 - 396
  • [30] Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma
    Hiraoka, Atsushi
    Kumada, Takashi
    Atsukawa, Masanori
    Hirooka, Masashi
    Tsuji, Kunihiko
    Ishikawa, Toru
    Takaguchi, Koichi
    Kariyama, Kazuya
    Itobayashi, Ei
    Tajiri, Kazuto
    Shimada, Noritomo
    Shibata, Hiroshi
    Ochi, Hironori
    Tada, Toshifumi
    Toyoda, Hidenori
    Nouso, Kazuhiro
    Tsutsui, Akemi
    Nagano, Takuya
    Itokawa, Norio
    Hayama, Korenobu
    Imai, Michitaka
    Joko, Kouji
    Tanaka, Hironori
    Tamai, Tsutomu
    Koizumi, Yohei
    Hiasa, Yoichi
    Michitaka, Kojiro
    Kudo, Masatoshi
    ONCOLOGY, 2019, 97 (05) : 277 - 285
12345